Table 1. Beta 2 Specific Sympathomimetic Bronchodilators
Generic Name
Brand Names
|
Routes of
Administration
|
Normal Adult
Dosage
|
Onset of
Action (Min.)
|
Duration
(Hours)
|
|
Albuterol
Proventil
Ventolin
|
Nebulizer |
2.5 - 5 mg Q4-6 Hrs |
5 |
4 to 6 |
MDI (90mcg/puff) |
1-3 puffs Q4-6 Hrs |
5 |
4 to 6 |
Tablets |
2 to 4 mg Q6-12 Hrs |
30 |
6 to 12 |
|
Levalbuterol
Xopenex
|
Nebulizer |
.63-1.25mg Q6-8 Hrs |
5 to 10 |
6 to 8 |
|
|
|
|
|
|
|
|
|
Bitolterol
Tornalate
|
Nebulizer |
2.5 mg Q6-8 Hrs |
4 |
6 to 8 |
MDI (0.37mg/puff) |
2 puffs Q6-8 Hrs |
|
|
|
Pirbuterol
Maxair
|
MDI (0.2mg/puff) |
2 puffs Q4-6 Hrs |
5 |
5 |
|
|
|
|
|
Terbutaline
Brethaire
Brethine
Bricanyl
|
MDI (0.2 mg/puff) |
2 puffs Q4-6 Hrs |
5 |
4 to 8 |
Tablets |
2.5 to 5 mg TID |
30 |
6 to 8 |
Subcutaneous |
.25mg Q 8 Hrs |
5 |
6 to 8 |
|
|
|
|
|
Salmeterol
Serevent
|
MDI (25mcg/puff) |
2 puffs Q12 Hrs |
20 |
12 |
DPI Diskus (25mcg/puff)
|
2 puffs Q 12 Hrs
|
20
|
12
|
Table 2. Other Sympathomimetic Bronchodilators
Generic Name
Brand Names
(*Receptors)
|
Routes of Administration
|
Normal Adult Dosage
|
Onset of Action
(Minutes)
|
Duration
(Hours)
|
 
|
Isoetherine
Bronkosol
Bronkometer
(B2++, B1+) |
Nebulizer |
2.5-5 mg Q4-6 Hrs |
5 |
4 |
MDI (340mcg/puff) |
2 puffs QID |
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
Metaproterenol
Metaprel
Alupent
(B2++, B1+) |
Nebulizer |
15 mg Q 4 Hrs |
5 |
3 to 4 |
MDI (.65mg/puff) |
2-3 puffs Q 4 Hrs |
5 |
3 to 4 |
Tablets |
10-20 mg Q6-8 Hrs |
30 |
6 to 8 |
 
|
Isoproterenol
Isuprel
(B1++, B2++) |
Nebulizer |
.25 to .5 cc PRN |
1 |
1 |
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
Racemic Epinephrine
Vaponefrin
micoNephrine
(A+, B1+, B2+) |
Nebulizer |
.25 to .5 cc PRN |
10 |
1 to 4 |
 
|
 
|
 
|
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
Epinephrine
(A++,B1++,B2++) |
I.V. or Intratracheal |
.05 to 1.0 mg PRN |
1 |
1 to 3 |
(.1% solution) |
&/or 1-4 mcg/min |
 
|
 
|
 
|
SQ (.1% solution) |
.1 to .5 cc PRN |
1 |
1 to 3 |
 
|
Nebulizer (1% sol) |
2.5 to 5 mg PRN |
1 |
1 to 3 |
 
|
*Receptors - Describes the specificity of the drug for certain
receptors.
A= alpha, B1= beta 1, B2= beta 2.
++ Strong stimulation of receptor.
+ Moderate stimulation of receptor. |
 
|
Racemic epinephrine is used primarily for the alpha effects of
reducing
edema in the upper airway, reducing stridor, and treating croup.
|
 
|
Epinephrine is used primarily in emergency situations, such as
status asthmaticus and cardiopulmonary arrest. |
Table 3. Parasympatholytic (Anticholinergic) Bronchodilators
Generic Name
Brand Names
|
Routes of
Administration
|
Normal Adult
Dosage
|
Onset of
Action
(Minutes)
|
Duration
(Hours)
|
|
Ipratropium bromide
Atrovent
|
Nebulizer |
0.5 mg QID |
20 |
5 to 8 |
MDI (18mcg/puff) |
2 puffs QID |
|
|
|
Atropine sulfate |
I.V. or Intratracheal |
0.5-2.0mg PRN |
5 |
1 to 4 |
Nebulizer |
1.0 mg QID |
5 to 20 |
1 to 4 |
Xanthines
Xanthine drugs inhibit the enzyme phosphodiesterase, which degrades
cyclic AMP. This results in relaxation of the bronchial airways and
pulmonary blood vessels.
Xanthines have other effects including cardiac stimulation, coronary
vasodilation, diuresis, cerebral stimulation, and skeletal muscle
stimulation.
The most commonly used xanthines are theophylline and aminophylline.
Theophylline (Theo-Dur, Slo Bid, Theovent, Uniphyl) is given orally by
tablet, capsule, or syrup. Aminophylline is given via I.V.
(intravenously). The normal adult loading dosage for emergency relief of
bronchospasms is 5 to 7.5 mg. given intravenously.
The normal adult dosage for maintenance therapy is:
- Orally: 300 to 1200 mg daily divided into doses every 6 to 8
hours.
- Oral sustained release tablets are given every 12 to 24 hours.
- I.V.: 0.5 to 0.9 mg/kg hourly.